3-69122135-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_198271.5(LMOD3):c.252G>A(p.Met84Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0016 in 1,612,738 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0089 ( 17 hom., cov: 32)
Exomes 𝑓: 0.00084 ( 14 hom. )
Consequence
LMOD3
NM_198271.5 missense
NM_198271.5 missense
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 6.17
Publications
1 publications found
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
LMOD3 Gene-Disease associations (from GenCC):
- nemaline myopathy 10Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0067123175).
BP6
Variant 3-69122135-C-T is Benign according to our data. Variant chr3-69122135-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 435783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00889 (1354/152256) while in subpopulation AFR AF = 0.0307 (1275/41552). AF 95% confidence interval is 0.0293. There are 17 homozygotes in GnomAd4. There are 644 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR,AD gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LMOD3 | ENST00000420581.7 | c.252G>A | p.Met84Ile | missense_variant | Exon 1 of 3 | 1 | NM_198271.5 | ENSP00000414670.3 | ||
| LMOD3 | ENST00000475434.1 | c.252G>A | p.Met84Ile | missense_variant | Exon 2 of 4 | 5 | ENSP00000418645.1 | |||
| LMOD3 | ENST00000489031.5 | c.252G>A | p.Met84Ile | missense_variant | Exon 2 of 4 | 2 | ENSP00000417210.1 |
Frequencies
GnomAD3 genomes AF: 0.00885 AC: 1346AN: 152138Hom.: 17 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1346
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00228 AC: 563AN: 246844 AF XY: 0.00171 show subpopulations
GnomAD2 exomes
AF:
AC:
563
AN:
246844
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000837 AC: 1222AN: 1460482Hom.: 14 Cov.: 31 AF XY: 0.000724 AC XY: 526AN XY: 726362 show subpopulations
GnomAD4 exome
AF:
AC:
1222
AN:
1460482
Hom.:
Cov.:
31
AF XY:
AC XY:
526
AN XY:
726362
show subpopulations
African (AFR)
AF:
AC:
1022
AN:
33462
American (AMR)
AF:
AC:
57
AN:
44586
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26086
East Asian (EAS)
AF:
AC:
0
AN:
39630
South Asian (SAS)
AF:
AC:
2
AN:
85918
European-Finnish (FIN)
AF:
AC:
0
AN:
53316
Middle Eastern (MID)
AF:
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
30
AN:
1111378
Other (OTH)
AF:
AC:
109
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00889 AC: 1354AN: 152256Hom.: 17 Cov.: 32 AF XY: 0.00865 AC XY: 644AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
1354
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
644
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
1275
AN:
41552
American (AMR)
AF:
AC:
62
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68022
Other (OTH)
AF:
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
65
130
195
260
325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
114
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
336
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Aug 24, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nemaline myopathy 10 Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
P;P;P
Vest4
MutPred
Gain of glycosylation at S81 (P = 0.0162);Gain of glycosylation at S81 (P = 0.0162);Gain of glycosylation at S81 (P = 0.0162);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.